P17.56 A 3-DIMENSIONAL MATRIX ASSAY TO HELP PREDICT TREATMENT RESPONSE TO TEMOZOLOMIDE IN PATIENTS WITH GLIOBASTOMA: UPDATE OF RESULTS AND SUBGROUP ANALYSIS OF PATIENTS UNDERGOING MGMT TESTING

INTRODUCTION: Usual treatment for glioblastoma is surgical resection, if possible, followed by radiotherapy with adjuvant chemotherapy using temozolomide. However a significant number of patients have a short response to temozolomide and subsequently a poorer prognosis. We investigated the possibili...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neuro-oncology (Charlottesville, Va.) Va.), 2014-09, Vol.16 (suppl 2), p.ii100-ii100
Hauptverfasser:	Megyesi, J. F., Costello, P., McDonald, W., Macdonald, D., Easaw, J.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!